| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/06/2008 | US20080057584 Using vector transformation to express glucose transport protein (GLUT-1) in mammalian cells; prevention and treatment of apoptosis, necrosis and proliferation inhibition |
| 03/06/2008 | US20080057579 Methods and products for manipulating hematopoietic stem cells |
| 03/06/2008 | US20080057577 Alkane Oxidation By Modified Hydroxylases |
| 03/06/2008 | US20080057566 Bacterial host cell for the direct expression of peptides |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057564 Nucleotide sequences coding mitotic regulatory proteins for use identifying modulators of plant development |
| 03/06/2008 | US20080057549 Rhodococcus nitrile hydratase |
| 03/06/2008 | US20080057540 Novel DKR polypeptides |
| 03/06/2008 | US20080057539 Glutamate transporter associated proteins and methods of use thereof |
| 03/06/2008 | US20080057537 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 03/06/2008 | US20080057522 Method for Screening Agents Modulating Ikbalpha Protein Ubiquitination and Means for Carrying out Said Method |
| 03/06/2008 | US20080057519 Monoclonal antibody specific for b-cell chronic lymphocytic leukemia cell surface protein; diagnosing cell proliferative disorders of blood |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
| 03/06/2008 | US20080057509 Defects in Periaxin Associated with Myelinopathies |
| 03/06/2008 | US20080057506 Polycystic xidney disease PKD2 gene and uses thereop |
| 03/06/2008 | US20080057504 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 03/06/2008 | US20080057501 Detection of Extracellular Tumor-Associated Nucleic Acid in Blood Plasma or Serum using Nucleic Acid Amplification Assay |
| 03/06/2008 | US20080057492 Interacting site for gp41 on gp120 of hiv-1 |
| 03/06/2008 | US20080057491 Atherosclerosis; thrombosis; enzyme inhibitors; drug screening |
| 03/06/2008 | US20080057085 Unique DNA and polypeptide sequences based on the circumsporozoite protein of Plasmodium vivax |
| 03/06/2008 | US20080057082 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | US20080057067 Immunogenic polypeptide fragments and vaccines; outer membrane proteins; prevention of infections including meningitis |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057058 Uses of il-23 agonists and antagonists; related reagents |
| 03/06/2008 | US20080057036 comprising a Picornavirus capable of lytically infecting or killing a cell substantially in the absence of intercellular adhesion molecule |
| 03/06/2008 | US20080057006 genetic vaccines comprising a recombination activating gene (rag) nucleotide sequence, used to code polypeptides, for the prevention and/or treatment of periodontal diseases, caused by infection by Porphyromonas gingivalis |
| 03/06/2008 | US20080057004 Albumin-insulin fusion proteins |
| 03/06/2008 | CA2669812A1 Method for increasing resistance to pathogens in transgenic plants |
| 03/06/2008 | CA2662172A1 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
| 03/06/2008 | CA2662062A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
| 03/06/2008 | CA2662026A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 03/06/2008 | CA2661995A1 Antigenic protein conjugates and process for preparing same |
| 03/06/2008 | CA2661848A1 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 03/06/2008 | CA2661599A1 Fusion proteins comprising tnf and fibritin trimerization domain |
| 03/06/2008 | CA2660732A1 Methods relating to peripheral administration of nogo receptor polypeptides |
| 03/06/2008 | CA2658736A1 Method for the production of insulin-like growth factor-i |
| 03/05/2008 | EP1895017A2 Use of A33 antigens and JAM-IT |
| 03/05/2008 | EP1895011A1 Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
| 03/05/2008 | EP1895006A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1895004A1 Human hippocalcin gene variant associated with cancers |
| 03/05/2008 | EP1894945A2 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 03/05/2008 | EP1894944A1 Methods for conversion of interferon isoforms and products thereof |
| 03/05/2008 | EP1894943A2 Purification of peptides from colostrum |
| 03/05/2008 | EP1894942A1 Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
| 03/05/2008 | EP1894941A1 Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens |
| 03/05/2008 | EP1894940A1 TNF superfamily fusion proteins |
| 03/05/2008 | EP1894939A1 Novel supertag and its use |
| 03/05/2008 | EP1894574A1 Anti-cancer agent comprising protein c inhibitor |
| 03/05/2008 | EP1893775A2 Alternative splicing isoform of lox-1 protein encoding gene, and uses thereof |
| 03/05/2008 | EP1893765A1 A process for preparing (2r,3s)-1,2-epoxy-3-(protected)amino-4-substituted butane and intermediates thereof |
| 03/05/2008 | EP1893644A2 Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (plad) of tumor necrosis factor receptors |
| 03/05/2008 | EP1893643A1 Compositions and methods for preventing or treating hiv infection |
| 03/05/2008 | EP1893642A2 High affinity melan-a t cell receptors |
| 03/05/2008 | EP1893641A2 Mutants of human app and their use for the production of transgenic animals |
| 03/05/2008 | EP1893640A2 Composition comprising fractions or sub-fractions of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmani |
| 03/05/2008 | EP1893639A2 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
| 03/05/2008 | EP1893638A2 Insect-specific protease recognition sequences |
| 03/05/2008 | EP1893637A1 Dengue serotype 1 attenuated strain |
| 03/05/2008 | EP1893636A2 Hepatitis c virus nucleic acid vaccine |
| 03/05/2008 | EP1893635A2 Anchored transferrin fusion protein libraries |
| 03/05/2008 | EP1893633A2 Angiotensin i - converting enzyme (ace) inhibitors |
| 03/05/2008 | EP1893632A2 Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine |
| 03/05/2008 | EP1893240A2 Transmucosal delivery of peptide derivatives |
| 03/05/2008 | EP1893239A2 Transglutaminase mediated conjugation of growth hormone |
| 03/05/2008 | EP1893238A1 Macromolecular conjugates of bone morphogenetic protein-7 |
| 03/05/2008 | EP1893229A2 Improved human interferon molecules and their uses |
| 03/05/2008 | EP1893228A2 Chimericpoly peptides and the therapeutic use thereof against a flaviviridae infection |
| 03/05/2008 | EP1893043A2 Reduced risk tobacco products and methods of making same |
| 03/05/2008 | EP1893032A2 Mutant strains of lactic acid bacteria having a non-phosporylable lactose permease |
| 03/05/2008 | EP1725662A4 Infectious aetiology of prostatic disease and methods to identify causative agents |
| 03/05/2008 | EP1708561A4 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor |
| 03/05/2008 | EP1661913B1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 03/05/2008 | EP1613343A4 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 03/05/2008 | EP1583504A4 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 03/05/2008 | EP1576178A4 Cell proliferation-related polypeptides and uses therefor |
| 03/05/2008 | EP1564236B1 Polyalkylen glycol derivative |
| 03/05/2008 | EP1282710B1 Fish vaccine against piscirickettsia salmonis |
| 03/05/2008 | EP1214418B1 Nucleic acid which is obtained from tetrahymena and which codes for a delta-6-desaturase, the production thereof and use |
| 03/05/2008 | EP1200575A4 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 03/05/2008 | EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics |
| 03/05/2008 | EP1030862B1 Viral clearance process |
| 03/05/2008 | EP0690912B1 Recombinant avian adenovirus vector |
| 03/05/2008 | CN101137751A Molybdenum transporter and gene thereof |
| 03/05/2008 | CN101137669A Method for cleaning marine collagen and the treatment thereof to form porous sponges |
| 03/05/2008 | CN101137668A Compositions and methods related to soluble g-protein coupled receptors (sgpcrs) |
| 03/05/2008 | CN101137667A Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 03/05/2008 | CN101137666A HIV Vif mutant |
| 03/05/2008 | CN101134967A Vitreoscilla hemoglobin mutant and gene and application thereof |
| 03/05/2008 | CN101134966A Modified nucleic acid sequences and method to increasing mrna levels and protein expression in cell systems |
| 03/05/2008 | CN101134964A Production method of recombinant human glandulae parathyroideae (1 to 34 peptide) |
| 03/05/2008 | CN101134963A Cascade expression method of recombinant human glandulae parathyroideae (1 to 34 peptide) |
| 03/05/2008 | CN101134780A Polypeptide analogue for blocking NR2B signal path and preparation method and medical usage thereof |
| 03/05/2008 | CN101134776A Method for preparing alpha1-antitrypsin |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134770A Hemoglobin gel chromatography method |
| 03/05/2008 | CN101134102A 5T4 tumour-expressed antigen |